Studies are being conducted to prove that Vitamin B17 can help in the treatment of cancer. It is believed presently that amygdalin content in the Vitamin is a cancer-fighting agent. It is not widely available in the market as it is not much attractive to the pharma industries from the commercial point of view. From this, it is safe to assume that the life of cancer suffering patients is not much important compared to the earnings of the doctors and high-priced chemotherapies.
